A Quick Reference Chart on Cross Resistance Between Anticancer Patients
Overview
Pharmacology
Authors
Affiliations
Violations of robustness trade-offs.
Kitano H Mol Syst Biol. 2010; 6:384.
PMID: 20571533 PMC: 2913402. DOI: 10.1038/msb.2010.40.
Predictive tests in cancer chemotherapy. A reappraisal.
Osieka R, Seeber S, SCHMIDT C Klin Wochenschr. 1984; 62(5):203-12.
PMID: 6371370 DOI: 10.1007/BF01721045.
Robertson S, Ling V, Stanners C Mol Cell Biol. 1984; 4(3):500-6.
PMID: 6144041 PMC: 368728. DOI: 10.1128/mcb.4.3.500-506.1984.
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Stephens T, Adams K, Peacock J Br J Cancer. 1986; 53(2):237-45.
PMID: 3954945 PMC: 2001330. DOI: 10.1038/bjc.1986.41.
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
Institoris E, Szikla K, Otvos L, GAL F Cancer Chemother Pharmacol. 1989; 24(5):311-3.
PMID: 2758560 DOI: 10.1007/BF00304764.